About TransMedics
TransMedics is a publicly listed company based in Andover (United States) founded in 1998. Developer of organ transplantation technology. TransMedics has raised $265.55 million across 16 funding rounds from investors including Canadian Imperial Bank of Commerce, United Therapeutics and Kleiner Perkins. The company has 728 employees. TransMedics has completed 2 acquisitions, including Summit Aviation and TransMedics Aviation. Its website transmedics.com draws about 24 thousand monthly visits. TransMedics offers products and services including OCS Lung, OCS Heart, OCS Liver, and OCS DCD Heart. Its focus areas include Life Sciences, Transplant Medicine, Medical Devices and Organ Preservation System. Its competitors include Paragonix Technologies, Bridge to Life and Vascular Perfusion; 3 of its 3 listed competitors have raised funding.
Company details
TransMedics was founded in 1998 in Andover, United States, within the medical device sector focused on organ transplantation. The Organ Care System (OCS) has been created as a portable technology that keeps organs functioning outside the body, featuring a wireless monitor, organ-specific perfusion module, and solution set. Versions for heart, lungs, and liver are available, with commercial distribution occurring in Europe and Australia.
- Headquarters Andover, United States
- Employees 728
- Stage Public
- SectorsHealthcare
- Website transmedics.com
- Social LinkedIn X Facebook
- Legal Name Transmedics Group, Inc.
- Annual Revenue$605.49 M (USD)37.13as on Dec 31, 2025
- Net Profit$190.29 M (USD)436.58as on Dec 31, 2025
- EBITDA$135.77 M (USD)137.13as on Dec 31, 2025
- Total Equity Funding$265.55M (USD)
in 16 rounds
- Latest Funding Round$60M (USD), Debt – Conventional
Sep 2022
- InvestorsCanadian Imperial Bank of Commerce
& 15 more
- Employee Count728
- Investments & AcquisitionsSummit Aviation
& 1 more
Products & Services of TransMedics
TransMedics offers a comprehensive portfolio of products and services, including OCS Lung, OCS Heart, OCS Liver, and OCS DCD Heart.
Technology for preserving lungs during transplantation procedures
Device for maintaining heart viability in transplants
System to preserve livers for successful transplantation
Approved technology for hearts from donation after circulatory death
Funding Insights of TransMedics
TransMedics has successfully raised a total of $265.55M across 16 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $60 million completed in September 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $265.55M
- Total Rounds 16
- Last Round Debt – Conventional — $60M
- First Round $8M
(Sep 2000)
- Investors Count 16
Latest 10 of 16 funding rounds of TransMedics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2022 | $60M | Debt – Conventional | – | – | |
| Jul 2016 | $63.73M | Series F | – | Pharmstandard International, BioStar Capital | |
| Sep 2015 | $499,998 | Series F | – | – | – |
| May 2015 | $20M | Series F | – | – | – |
| Nov 2012 | $36.15M | Series E | – | Abrams Capital, Hercules Capital | – |
| Aug 2011 | $5.92M | Series E | – | – | – |
| Feb 2010 | $36M | Series E | – | Foundation Capital, Kleiner Perkins | |
| Dec 2009 | $3.57M | Debt – Conventional | – | – | – |
| Jul 2009 | $2.5M | Debt – Conventional | – | – | – |
| Jun 2008 | $11.26M | Series D | – | – | – |
16 investors in total: 16 institutional.
Investors in TransMedics
TransMedics has secured backing from 16 investors, including institutional and venture fund investors. Prominent investors backing the company include Canadian Imperial Bank of Commerce, United Therapeutics and Kleiner Perkins.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investments are managed by Abrams Capital across the United States. | abramscapital.com | Boston, United States | ||
Life sciences-focused venture capital firm | 1999 | flagshippioneering.com | Cambridge, United States | |
Venture capital firm investing in early-stage tech startups | 1972 | kleinerperkins.com | Menlo Park, United States | |
Healthtech startups are funded by BioStar Capital's venture capital efforts. | biostarcapital.com | Charlevoix, United States | ||
Venture debt financing is provided to companies in multiple sectors. | 2003 | htgc.com | Palo Alto, United States | |
Venture capital firm focused on early-stage fintech, enterprise, web 3, consumer, and multiple sectors | 1995 | foundationcapital.com | Palo Alto, United States | |
Private equity firm focused on mid-market businesses | 1945 | 3i.com | London, United Kingdom | |
Venture capital firm focused on healthcare companies | altapartners.com | Jackson, United States | ||
Venture capital firm | vpcp.com | Santa Barbara, United States | ||
PE firm investing in the US | sherbrookecapital.com | Wellesley, United States |
Investor details for TransMedics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of TransMedics
94 people are tracked at TransMedics (30 in leadership, 3 in board & advisors, 61 in team); the tracked headcount is 728.
| Name | Role | Group |
|---|---|---|
Anil Ranganath | Senior Vice President, General Counsel & Corporate Secretary | Leadership |
Susan Goodman | VP of HR | Leadership |
Miriam Provost | VP of Global Regulatory Affairs | Leadership |
Tamer Khayal | Chief Commercial Officer | Leadership |
Kimberly Nicoll | Vice President, US Transplant Reimbursement | Leadership |
Waleed Hassanein | President & CEO | Leadership |
Dionne Garon | Director Of Payroll And Equity Administration | Leadership |
Hall Lewallen | Director Of Operations, Aviation | Leadership |
Leah Anciello | Sr. Director, Total Rewards & HR Operations | Leadership |
Jared P. | Director Of Aviation Safety And Security | Leadership |
Craig Hanrahan | Vp, Information Security & Infrastructure Operations | Leadership |
Kelvin T. | Director Of Software | Leadership |
Rod Ennis | Vice President, Aviation | Leadership |
Richard Good | Part 135 Director Of Training | Leadership |
Pamela Baxter | Chief Information Officer | Leadership |
Lisa M. | Director Of Aviation Accounting | Leadership |
John Carey | Vice President Of Operations | Leadership |
Dennis Sousa | Director Of Laboratory And Surgical Operations | Leadership |
Ahmed Elbetanony | Product Director | Leadership |
Laura A. Brown | Senior Principal Clinical Talent Aquisitions Partner | Leadership |
74 more people are available in the full profile.
Complete people profiles for TransMedics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of TransMedics
TransMedics is a publicly listed company on the NASDAQ with ticker symbol TMDX in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date02 May 2019
- Listed onNASDAQ: TMDX
- Listed entityTransMedics Group, Inc.
- Exchange sectorHealth technology
- ISINUS89377M1099
- Share price$79.14 (+1.23% on the day) · 2026-10-13
- Market capitalisation$2.74B
- Price to earnings20.6
- EPS (diluted, trailing year)$3.84
- Volume (last session)1,026,032
Financials of TransMedics
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $605.5M | $190.3M | $135.8M |
| 2024 | $441.5M | $35.5M | $57.2M |
| 2023 | $241.6M | -$25.0M | $8.8M |
| 2022 | $93.5M | -$36.2M | -$27.2M |
| 2021 | $30.3M | -$44.2M | -$36.8M |
Detailed financial statements for TransMedics
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by TransMedics
TransMedics has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Summit Aviation and TransMedics Aviation.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Full service aviation centre offering aircraft maintenance, repair, modifications, flight school, private jet charter, and aircraft management solutions | summit-aviation.com | Middletown, United States | 1960 | Aug 2023 | •••• | |
Aviation degrees and flight training services are provided. | flysummit.com | Belgrade, United States | 2000 | Aug 2023 | •••• |
Complete acquisition details for TransMedics
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of TransMedics
6 dated milestones of TransMedics across 25 years, from founding to its latest funding, stage changes and deals.
- Founded TransMedics is founded.
- Funding First funding round of $8.0M.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Debt – Conventional, of $60.0M.
- Acquisition Acquires TransMedics Aviation.
- Acquisition Acquires Summit Aviation.
Competitors of TransMedics
TransMedics has 3 listed competitors in our database, 3 of them funded. They include Paragonix Technologies, Bridge to Life and Vascular Perfusion.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| paragonixtechnologies.com | 2010 | Boston, United States | $25.1M | Organ preservation and transport systems are developed for transplants. | ||
| bridgetolife.com | 2012 | Columbia, United States | $57M | Cold storage solutions for organ transplant preservation are provided. | ||
| vascularperfusion.solutions | 2016 | San Antonio, United States | $151.67M | Developer of a device for organ preservation |
Detailed competitors of TransMedics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of TransMedics
The website of TransMedics (transmedics.com) receives about 24.2K visits a month.
- Monthly visits24.2K
▲ 10.1% vs previous month
Websites whose visitors overlap most with TransMedics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
transmedicgroup.com | transmedicgroup.com | 100% | #2,075,800 | – | |
transplants.ucla.edu | transplants.ucla.edu | 55% | – | ||
trans-medic.com | trans-medic.com | 33% | – | ||
en.wikipedia.org | en.wikipedia.org | 32% | – | ||
transmedicsraleigh.com | transmedicsraleigh.com | 26% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 6 similar websites and full traffic analytics for TransMedics
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 6 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Transplant Medicine
3 companies that operate in the same segment as TransMedics (Transplant Medicine) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medical solutions for transplant patients are developed and provided. | 1998 | Brisbane, California, United States | USD 138.21 M | USD 379.81 M | 650 | |
Human tissue-based products are developed for vascular disease applications. | 2004 | Morrisville, United States | USD 424.76 M | USD 2.04 M | 220 | |
Next-generation medicines for CNS and immunological disorders are developed. | 2007 | New York, New York, United States | USD 4.45 M | USD 13.11 M | 81 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Transmedics
Complete news archive for TransMedics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about TransMedics
TransMedics was founded in 1998 and raised its 1st funding round 2 years after it was founded.
TransMedics is headquartered in Andover, United States. It is registered at Andover, Massachusetts, United States.
TransMedics is a funded company, having raised a total of $265.55M across 16 funding rounds to date. The company's 1st funding round was a Series D of $11.26M, raised on Sep 2000.
TransMedics has 728 employees.
Annual revenue of TransMedics is $605.49M as on Dec 31, 2025.
TransMedics was founded in 1998 in Andover, United States, within the medical device sector focused on organ transplantation. The Organ Care System (OCS) has been created as a portable technology that keeps organs functioning outside the body, featuring a wireless monitor, organ-specific perfusion module, and solution set. Versions for heart, lungs, and liver are available, with commercial distribution occurring in Europe and Australia.
TransMedics's top competitors include Paragonix Technologies, Bridge to Life and Vascular Perfusion.
TransMedics offers OCS Lung, OCS Heart, OCS Liver, and OCS DCD Heart.
Yes, TransMedics is publicly traded on NASDAQ under the ticker symbol TMDX.
TransMedics has made 2 acquisitions, including Summit Aviation, and TransMedics Aviation.
TransMedics has 16 investors. Key investors include Canadian Imperial Bank of Commerce, United Therapeutics, Kleiner Perkins, Hercules Capital, and Flagship Pioneering.